Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa

NCT00336154 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Epidermolysis Bullosa

Interventions

DRUG: tetracyclin

Sponsor

Rambam Health Care Campus